Lesayao, Nercita .

HRN: 14-82-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2022
CEFUROXIME 750MG (VIAL)
12/18/2022
12/25/2022
IVTT
750mg
Q8h
Soft Tissue Contusions
12/19/2022
CEFTRIAXONE 1G (VIAL)
12/19/2022
12/25/2022
IV
2g
OD
T/C Miliary Tb
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: